FORUM INSTITUT
FORUM · Institut für Management GmbH
Vangerowstraße 18
69115 Heidelberg
Email: service@forum-institut.de
Phone: +49 6221 500-500
Fax: +49 6221 500-505
Course Performance Driven Payments in Europe
Performance-Driven Payments
in Europe
2019-09-18 2019-09-18 Adina Apartment Hotel Checkpoint Charlie Krausenstr. 35-36 10117 Berlin berlincc@adina.eu +49 30 200 767 0 +49 30 200 767 599

Performance-Driven Payments in Europe

Payment of high-priced drugs in the UK, BeNeLuxAI, Italy and Germany

Payment of high-priced drugs in the UK, BeNeLuxAI, Italy and Germany - this is where you'll get to know current and upcoming pricing models.
Topics
  • Reimbursement models in the UK for highly specialised technologies
  • BeNeLuxAI - HTA and pricing coordination
  • Performance-driven payments in Germany through the GSAV?
  • Adapting risk-sharing schemes for ATMPs in Italy?

Aims and objectives

The German draft drug law GSAV foresees registries for orphan drugs; first performance-driven payment contracts have already been established. Other countries, such as Italy, have used this pricing model for quite some time.

This conference compiles Europe's various tendencies in regard to the payment of high-priced innovative drugs, which are about to enter the European market.

After attending this meeting, you will be aware of the existing payment models and be knowledgeable about the upcoming payment trends in Europe. Lastly, you will get to know possibilities you have in the direct contraction situation with payers.

Who should attend
This conference addresses the needs of employees in the pharmaceutical industry responsible for market access activities in the various national European markets.

Those involved in value-assessment preparation and pricing activities will benefit particularly from this conference.
Your speakers
Chair
Dr. Alexander Natz, LL.M.
EUCOPE - European Confederation of Pharmaceutical Entrepreneurs, Brussels, Belgium


Speakers
Oswald Bentinck
AveXis, Zürich, SWITZERLAND

Adam Hutchings
Dolon Ltd, London, UNITED KINGDOM

Dr Diane Kleinermans
Ministry of Public Health and Social Security, Belgium, Bruxelles, BELGIUM

Sheela Upadhyaya
National Institute for Health and Care Excellence Centre for Health Technology Evaluation London, GREAT BRITAIN

Dr Entela Xoxi
Università Cattolica del Sacro, Rome


Go forward

Abbreviations, Glossary

List of abbreviations

Many abbreviations for processes, documents and authorities, amongst others, are used in all regulatory areas. We have compiled the most important ones for you.

Our list of abbreviations can be freely downloaded here.

Details

Abbreviations, Glossary

List of abbreviations

Many abbreviations for processes, documents and authorities, amongst others, are used in all regulatory areas. We have compiled the most important ones for you. Our list of abbreviations can be freely downloaded here.

Details

More on our quality criteria

Quality guaranteed!

IMI (Innovative Medicines Initiative) defined quality criteria for professional training and education. We follow these criteria and, as a signatory, we are an active partner in further developing and optimising the quality standards.

An aggregate evaluation of participants' feedback on all FORUM's healthcare training courses (evaluation period from 10.2017 - 09.2018 produced a result of 1.6 (based on a school grading system of 1-6).

Details